Search research articles
Contact Us
Filters
Showing results (61-70 of 110) with videos related to
Page
of 11
Sort By:
Lancet (London, England)
|
April 4, 1981
Urinary ethanol levels and diabetes
W D Alexander, P D Wills, N Eldred, et al.
Biochemical Pharmacology
|
February 1, 1972
Biliary excretion of 35 S-labelled propylthiouracil, methimazole and carbimazole in untreated and pentobarbitone pretreated rats
P D Papapetrou, B Marchant, H Gavras, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1993
A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment
D Reinwein, G Benker, J H Lazarus, et al.
Postgraduate Medical Journal
|
May 1, 1976
Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus
W D Alexander, R T Wensley, G Price, et al.
Metabolism: Clinical and Experimental
|
November 1, 1971
Concentration of 35S-propylthiouracil by the thyroid gland and its relationship to anion trapping mechanism
B Marchant, W D Alexander, J W Robertson, et al.
British Medical Journal
|
October 6, 1979
Trauma and severe proliferative retinopathy in diabetes mellitus
W D Alexander, M Kearns, E M Kohner, et al.
Clinical Endocrinology
|
November 1, 1975
35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid
J H Lazarus, B Marchant, W D Alexander, et al.
Clinical Endocrinology
|
January 1, 1973
Sequential assessment during drug treatment of thyrotoxicosis
W D Alexander, D G McLarty, P Horton, et al.
Endocrinology
|
March 1, 1977
Role of TSH in the changes in thyroidal metabolism of [35S]methimazole in phenobarbital and thyroxine-treated rats
J F Lees, W D Alexander, M Lewis, et al.
Clinical Science
|
June 1, 1973
The metabolism of 35S-labelled antithyroid drugs in thyrotoxic, adenomatous, neoplastic and normal human thyroid
J H Lazarus, B Marchant, W D Alexander, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 110) with videos related to
Sort By:
Page
of 11
Lancet (London, England)
|
April 4, 1981
Urinary ethanol levels and diabetes
W D Alexander, P D Wills, N Eldred, et al.
Biochemical Pharmacology
|
February 1, 1972
Biliary excretion of 35 S-labelled propylthiouracil, methimazole and carbimazole in untreated and pentobarbitone pretreated rats
P D Papapetrou, B Marchant, H Gavras, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1993
A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment
D Reinwein, G Benker, J H Lazarus, et al.
Postgraduate Medical Journal
|
May 1, 1976
Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus
W D Alexander, R T Wensley, G Price, et al.
Metabolism: Clinical and Experimental
|
November 1, 1971
Concentration of 35S-propylthiouracil by the thyroid gland and its relationship to anion trapping mechanism
B Marchant, W D Alexander, J W Robertson, et al.
British Medical Journal
|
October 6, 1979
Trauma and severe proliferative retinopathy in diabetes mellitus
W D Alexander, M Kearns, E M Kohner, et al.
Clinical Endocrinology
|
November 1, 1975
35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid
J H Lazarus, B Marchant, W D Alexander, et al.
Clinical Endocrinology
|
January 1, 1973
Sequential assessment during drug treatment of thyrotoxicosis
W D Alexander, D G McLarty, P Horton, et al.
Endocrinology
|
March 1, 1977
Role of TSH in the changes in thyroidal metabolism of [35S]methimazole in phenobarbital and thyroxine-treated rats
J F Lees, W D Alexander, M Lewis, et al.
Clinical Science
|
June 1, 1973
The metabolism of 35S-labelled antithyroid drugs in thyrotoxic, adenomatous, neoplastic and normal human thyroid
J H Lazarus, B Marchant, W D Alexander, et al.
Page
of 11